Cancer, immunodeficiency and antiretroviral treatment: Results from the Australian HIV Observational Database (AHOD)

HIV Medicine

Volumn 14, Issue 2, 2013, Pages 77-84

  Petoumenos, K ^a   van Leuwen, M T ^b,c   Vajdic, C M ^b,c   Woolley, I ^d,e   Chuah, J ^f   Templeton, D J ^a,g   Grulich, A E ^a   Law, M G ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e MONASH MEDICAL CENTRE   (Australia)

^f NONE   (Australia)

^g RPA Sexual Health   (Australia)

Author keywords

Antiretroviral treatment; Cancer; Cohort; HIV AIDS

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANUS CANCER; ARTICLE; CANCER INCIDENCE; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; GALLBLADDER CANCER; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LEUKEMIA; LIP CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SALIVARY GLAND CANCER; STOMACH CANCER; TONGUE CANCER;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGING; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS NEOPLASMS; AUSTRALIA; CD4 LYMPHOCYTE COUNT; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; LYMPHOMA, AIDS-RELATED; MALE; MELANOMA; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84871930145     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2012.01038.x     Document Type: Article

References (24)

1. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370: 59-67.
2. Patel P, Hanson DL, Sullivan PS etal. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 148: 728-736.
3. Seaberg EC, Wiley D, Martinez-Maza O etal. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer 2010; 116: 5507-5516.
4. Grulich AE. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation. Curr Opin HIV AIDS 2009; 4: 183-187.
5. van Leeuwen MT, Vajdic CM, Middleton MG etal. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS 2009; 23: 2183-2190.
6. Bedimo R, Chen RY, Accortt NA etal. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis 2004; 39: 1380-1384.
7. Franceschi S, Lise M, Clifford GM etal. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 2010; 103: 416-422.
8. Polesel J, Franceschi S, Suligoi B etal. Cancer incidence in people with AIDS in Italy. Int J Cancer 2010; 127: 1437-1445.
9. Engels EA, Pfeiffer RM, Goedert JJ etal. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006; 20: 1645-1654.
10. Mbulaiteye SM, Walters M, Engels EA etal. High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs. J Infect Dis 2006; 193: 422-426.
11. Polesel J, Clifford GM, Rickenbach M etal. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS 2008; 22: 301-306.
12. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285: 1736-1745.
13. Stebbing J, Gazzard B, Mandalia S etal. Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma. J Clin Oncol 2004; 22: 2177-2183.
14. Petoumenos K, Hui E, Kumarasamy N etal. Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors. J Int AIDS Soc 2010; 13: 51.
15. Powles T, Robinson D, Stebbing J etal. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009; 27: 884-890.
16. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 2003; 32: 527-533.
17. Grulich AE, Li Y, McDonald A, Correll PK, Law MG, Kaldor JM. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002; 16: 1155-1161.
18. Crum-Cianflone N, Hullsiek KH, Marconi V etal. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS 2009; 23: 41-50.
19. Australian HIV Observational Database. Rates of combination antiretroviral treatment change in Australia, 1997-2000. HIV Med 2002; 3: 28-36.
20. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118: 3030-3044.
21. Kinlen L. Infections and immune factors in cancer: the role of epidemiology. Oncogene 2004; 23: 6341-6348.
22. Vajdic CM, McDonald SP, McCredie MR etal. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823-2831.
23. Grierson J, Power J, Pitts M etal. HIV futures 6: making positive lives count. Monograph series number 74, The Australian Research Centre in Sex, Health and Society. 2009.
24. Pezzotti P, Phillips AN, Dorrucci M etal. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group. BMJ 1996; 313: 583-586.